| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cancer as an evolutionary and ecological process.
|
Nat Rev Cancer
|
2006
|
9.33
|
|
2
|
Genetic clonal diversity predicts progression to esophageal adenocarcinoma.
|
Nat Genet
|
2006
|
6.71
|
|
3
|
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
|
Am J Gastroenterol
|
2007
|
3.00
|
|
4
|
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
|
Lancet Oncol
|
2005
|
2.40
|
|
5
|
Leukocyte telomere length predicts cancer risk in Barrett's esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
2.39
|
|
6
|
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
|
Clin Cancer Res
|
2006
|
2.24
|
|
7
|
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
|
PLoS Med
|
2007
|
2.23
|
|
8
|
Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus.
|
Cancer Res
|
2004
|
2.15
|
|
9
|
A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma.
|
Cancer Prev Res (Phila)
|
2010
|
1.89
|
|
10
|
The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma.
|
Cancer Res
|
2004
|
1.76
|
|
11
|
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
|
Nat Genet
|
2013
|
1.67
|
|
12
|
Focus on Barrett's esophagus and esophageal adenocarcinoma.
|
Cancer Cell
|
2004
|
1.57
|
|
13
|
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.
|
Nat Genet
|
2012
|
1.52
|
|
14
|
Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues.
|
Anal Chem
|
2006
|
1.49
|
|
15
|
Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.
|
Cancer Prev Res (Phila)
|
2008
|
1.43
|
|
16
|
Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer.
|
Am J Pathol
|
2002
|
1.39
|
|
17
|
Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model.
|
Carcinogenesis
|
2003
|
1.39
|
|
18
|
Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus.
|
Cancer Prev Res (Phila)
|
2013
|
1.31
|
|
19
|
Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.
|
Clin Gastroenterol Hepatol
|
2013
|
1.29
|
|
20
|
Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH.
|
Genes Chromosomes Cancer
|
2007
|
1.26
|
|
21
|
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.
|
J Natl Cancer Inst
|
2013
|
1.25
|
|
22
|
Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.22
|
|
23
|
Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.
|
Clin Cancer Res
|
2009
|
1.17
|
|
24
|
Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
1.14
|
|
25
|
Neosquamous epithelium does not typically arise from Barrett's epithelium.
|
Clin Cancer Res
|
2006
|
1.14
|
|
26
|
Chromosomal instability in Barrett's esophagus is related to telomere shortening.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.12
|
|
27
|
Natural selection in neoplastic progression of Barrett's esophagus.
|
Semin Cancer Biol
|
2005
|
1.10
|
|
28
|
Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
|
Hum Pathol
|
2006
|
1.08
|
|
29
|
The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
|
PLoS One
|
2013
|
1.08
|
|
30
|
Direct inference of SNP heterozygosity rates and resolution of LOH detection.
|
PLoS Comput Biol
|
2007
|
1.06
|
|
31
|
Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae.
|
Neoplasia
|
2002
|
1.03
|
|
32
|
Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus.
|
Cancer Res
|
2003
|
1.02
|
|
33
|
Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.
|
J Natl Cancer Inst
|
2003
|
0.99
|
|
34
|
NSAIDs modulate clonal evolution in Barrett's esophagus.
|
PLoS Genet
|
2013
|
0.98
|
|
35
|
Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.98
|
|
36
|
Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.
|
Clin Cancer Res
|
2008
|
0.98
|
|
37
|
Translational Research Working Group developmental pathway for biospecimen-based assessment modalities.
|
Clin Cancer Res
|
2008
|
0.95
|
|
38
|
Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.
|
PLoS One
|
2012
|
0.94
|
|
39
|
Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.
|
Am J Surg Pathol
|
2006
|
0.93
|
|
40
|
Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.92
|
|
41
|
Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.90
|
|
42
|
Application of sewage sludge and sewage sludge biochar to reduce polycyclic aromatic hydrocarbons (PAH) and potentially toxic elements (PTE) accumulation in tomato.
|
Environ Sci Pollut Res Int
|
2015
|
0.90
|
|
43
|
Deletion at fragile sites is a common and early event in Barrett's esophagus.
|
Mol Cancer Res
|
2010
|
0.89
|
|
44
|
Application of biomarkers in cancer risk management: evaluation from stochastic clonal evolutionary and dynamic system optimization points of view.
|
PLoS Comput Biol
|
2011
|
0.89
|
|
45
|
Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study.
|
Nutr Cancer
|
2008
|
0.89
|
|
46
|
Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.89
|
|
47
|
Warburg and Crabtree effects in premalignant Barrett's esophagus cell lines with active mitochondria.
|
PLoS One
|
2013
|
0.88
|
|
48
|
Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.87
|
|
49
|
Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity.
|
Cancer Biomark
|
2009
|
0.87
|
|
50
|
p16 mutation spectrum in the premalignant condition Barrett's esophagus.
|
PLoS One
|
2008
|
0.87
|
|
51
|
Environmental contextualisation of potential toxic elements and polycyclic aromatic hydrocarbons in biochar.
|
Environ Pollut
|
2012
|
0.86
|
|
52
|
Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage.
|
Cancer Causes Control
|
2014
|
0.85
|
|
53
|
Flow cytometric enrichment for respiratory epithelial cells in sputum.
|
Cytometry A
|
2004
|
0.85
|
|
54
|
Toxicity of polycyclic aromatic hydrocarbons to the nematode Caenorhabditis elegans.
|
J Toxicol Environ Health A
|
2009
|
0.83
|
|
55
|
Carcinogenic potential of soils contaminated with polycyclic aromatic hydrocarbons (PAHs) in Xiamen metropolis, China.
|
J Environ Monit
|
2012
|
0.83
|
|
56
|
Mechanistic insights into the role of river sediment in the attenuation of the herbicide isoproturon.
|
Environ Pollut
|
2012
|
0.82
|
|
57
|
Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study.
|
Am J Surg Pathol
|
2009
|
0.82
|
|
58
|
Earthworm assisted bioremediation of organic contaminants.
|
Environ Int
|
2008
|
0.81
|
|
59
|
Cyclodextrin enhanced biodegradation of polycyclic aromatic hydrocarbons and phenols in contaminated soil slurries.
|
Environ Sci Technol
|
2007
|
0.80
|
|
60
|
Mitigating heavy metal accumulation into rice (Oryza sativa L.) using biochar amendment--a field experiment in Hunan, China.
|
Environ Sci Pollut Res Int
|
2015
|
0.79
|
|
61
|
Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.
|
Am J Surg Pathol
|
2005
|
0.78
|
|
62
|
Prediction of PAH biodegradation in field contaminated soils using a cyclodextrin extraction technique.
|
J Environ Monit
|
2007
|
0.78
|
|
63
|
Sequential extraction of polycyclic aromatic hydrocarbons using subcritical water.
|
Chemosphere
|
2009
|
0.78
|
|
64
|
Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention.
|
BMC Med Inform Decis Mak
|
2014
|
0.77
|
|
65
|
Soil bacterial consortia and previous exposure enhance the biodegradation of sulfonamides from pig manure.
|
Microb Ecol
|
2012
|
0.77
|
|
66
|
Feasibility of RNA and DNA extraction from fresh pipelle and archival endometrial tissues for use in gene expression and SNP arrays.
|
Obstet Gynecol Int
|
2013
|
0.77
|
|
67
|
Reduced bioaccumulation of PAHs by Lactuca satuva L. grown in contaminated soil amended with sewage sludge and sewage sludge derived biochar.
|
Environ Pollut
|
2013
|
0.76
|
|
68
|
Prediction of mono- and polycyclic aromatic hydrocarbon degradation in spiked soils using cyclodextrin extraction.
|
Environ Pollut
|
2006
|
0.75
|
|
69
|
Assessing biodegradation potential of PAHs in complex multi-contaminant matrices.
|
Environ Pollut
|
2008
|
0.75
|
|
70
|
Prediction of polycyclic aromatic hydrocarbon biodegradation in contaminated soils using an aqueous hydroxypropyl-beta-cyclodextrin extraction technique.
|
Environ Toxicol Chem
|
2005
|
0.75
|
|
71
|
Towards a more appropriate water based extraction for the assessment of organic contaminant availability.
|
Environ Pollut
|
2005
|
0.75
|
|
72
|
Compatibility of hydroxypropyl-beta-cyclodextrin with algal toxicity bioassays.
|
Environ Pollut
|
2008
|
0.75
|
|
73
|
Influence of diesel concentration on the fate of phenanthrene in soil.
|
Environ Pollut
|
2005
|
0.75
|
|
74
|
Decision-makers' perspectives on the use of bioaccessibility for risk-based regulation of contaminated land.
|
Environ Int
|
2010
|
0.75
|
|
75
|
Beyond contaminated land assessment: on costs and benefits of bioaccessibility prediction.
|
Environ Int
|
2009
|
0.75
|
|
76
|
Prediction of microbial accessibility of carbon-14-phenanthrene in soil in the presence of pyrene or benzo[a]pyrene using an aqueous cyclodextrin extraction technique.
|
J Environ Qual
|
2007
|
0.75
|
|
77
|
The co-application of earthworms (Dendrobaena veneta) and compost to increase hydrocarbon losses from diesel contaminated soils.
|
Environ Int
|
2008
|
0.75
|
|
78
|
Environmentally friendly assessment of organic compound bioaccessibility using sub-critical water.
|
Environ Pollut
|
2008
|
0.75
|